Cell-free fetal DNA and spontaneous preterm birth

Reproduction

Volumn 155, Issue 3, 2018, Pages R137-R145

  Van Boeckel, Sara R ^a   Davidson, Donald J ^b   Norman, Jane E ^a   Stock, Sarah J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE FETAL DNA; DNA; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; CELL FREE NUCLEIC ACID;

ADVERSE OUTCOME; CELL FREE SYSTEM; HUMAN; NONHUMAN; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SPONTANEOUS PRETERM BIRTH; FEMALE; FETUS; GENETICS; INFLAMMATION; METABOLISM; PREGNANCY; PREMATURITY;

CELL-FREE NUCLEIC ACIDS; FEMALE; FETUS; HUMANS; INFLAMMATION; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH;

EID: 85042356179     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-17-0619     Document Type: Review

References (66)

1. Barber GN 2015 STING: infection, inflammation and cancer. Nature Reviews Immunology 15 760-770. (https://doi.org/10.1038/nri3921)
2. Bauer S 2006 Toll-erating self DNA. Nature Immunology 7 13-15. (https://doi.org/10.1038/ni0106-13)
3. Bauer M, Hutterer G, Eder M, Majer S, Leshane E, Johnson KL, Peter I, Bianchi DW & Pertl B 2006 A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome. Prenatal Diagnosis 26 831-836. (https://doi.org/10.1002/pd.1513)
4. Bianchi DW 2004 Circulating fetal DNA: its origin and diagnostic potential-a review. Placenta 25 (Supplement A) S93-S101. (https://doi.org/10.1016/j.placenta.2004.01.005)
5. Birch L, English CA, O'Donoghue K, Barigye O, Fisk NM & Keer JT 2005 Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clinical Chemistry 51 312-320. (https://doi.org/10.1373/clinchem.2004.042713)
6. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L et al. 2012 National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 379 2162-2172. (https://doi.org/10.1016/S0140-6736 (12) 60820-4)
7. Bollapragada S, Youssef R, Jordan F, Greer I, Norman J & Nelson S 2009 Term labor is associated with a core inflammatory response in human fetal membranes, myometrium, and cervix. American Journal of Obstetrics and Gynecology 200 104. e101-111.e101. (https://doi.org/10.1016/j.ajog.2008.08.032)
8. Cappelletti M, Della Bella S, Ferrazzi E, Mavilio D & Divanovic S 2016 Inflammation and preterm birth. Journal of Leukocyte Biology 99 67-78. (https://doi.org/10.1189/jlb.3MR0615-272RR)
9. Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF & Olson DM 2008 Inflammatory processes in preterm and term parturition. Journal of Reproductive Immunology 79 50-57. (https://doi.org/10.1016/j.jri.2008.04.002)
10. Conka J, Konečná B, Lauková L, Vlková B & Celec P 2017 Fetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mouse. Placenta 52 100-105. (https://doi.org/10.1016/j.placenta.2017.02.008)
11. Contro E, Bernabini D & Farina A 2017 Cell-free fetal DNA for the prediction of pre-eclampsia at the first and second trimesters: a systematic review and meta-analysis. Molecular Diagnosis and Therapy 21 125. (https://doi.org/10.1007/s40291-016-0245-9)
12. Dugoff L, Barberio A, Whittaker PG, Schwartz N, Sehdev H & Bastek JA 2016 Cell-free DNA fetal fraction and preterm birth. American Journal of Obstetrics and Gynecology 215 231. e1-231.e7. (https://doi.org/10.1016/j.ajog.2016.02.009)
13. Dwivedi DJ, Toltl LJ, Swystun LL, Pogue J, Liaw KL, Weitz JI, Cook DJ, Fox-Robichaud AE, Liaw PC & Canadian Critical Care Translational Biology Group 2012 Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Critical Care 16 R151. (https://doi.org/10.1186/cc11466)
14. Enninga EA, Nevala WK, Holtan SG & Markovic SN 2015 Immune reactivation by cell-free fetal DNA in healthy pregnancies repurposed to target tumors: novel checkpoint inhibition in cancer therapeutics. Frontiers in Immunology 6 424. (https://doi.org/10.3389/fimmu.2015.00424)
15. Farina A, LeShane ES, Romero R, Gomez R, Chaiworapongsa T, Rizzo N & Bianchi DW 2005 High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. American Journal of Obstetrics and Gynecology 193 421-425. (https://doi.org/10.1016/j.ajog.2004.12.023)
16. Fernando MR, Chen K, Norton S, Krzyzanowski G, Bourne D, Hunsley B, Ryan WL & Bassett C 2010 A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage. Prenatal Diagnosis 30 418-424. (https://doi.org/10.1002/pd.2484)
17. Furi I, Kalmár A, Wichmann B, Spisák S, Schöller A, Barták B, Tulassay Z & Molnár B 2015 Cell free DNA of tumor origin induces a 'metastatic' expression profile in HT-29 cancer cell line. PLoS ONE 10 e0131699. (https://doi.org/10.1371/journal.pone.0131699)
18. Gold B, Cankovic M, Furtado LV, Meier F & Gocke CD 2015 Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology. Journal of Molecular Diagnostics 17 209-224. (https://doi.org/10.1016/j.jmoldx.2015.02.001)
19. Goldenberg RL, Culhane JF, Iams JD & Romero R 2008 Epidemiology and causes of preterm birth. Lancet 371 75-84. (https://doi.org/10.1016/S0140-6736 (08) 60074-4)
20. Goulopoulou S, Wenceslau CF, McCarthy CG, Matsumoto T & Webb RC 2016 Exposure to stimulatory CpG oligonucleotides during gestation induces maternal hypertension and excess vasoconstriction in pregnant rats. American Journal of Physiology-Heart and Circulatory Physiology 310 H1015-H1025.
21. Hahn S, Huppertz B & Holzgreve W 2005 Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta 26 515-526. (https://doi.org/10.1016/j.placenta.2004.10.017)
22. Hahn S, Giaglis S, Buser A, Hoesli I, Lapaire O & Hasler P 2014 Cellfree nucleic acids in (maternal) blood: any relevance to (reproductive) immunologists? Journal of Reproductive Immunology 104-105 26-31. (https://doi.org/10.1016/j.jri.2014.03.007)
23. Herrera CA, Stoerker J, Carlquist J, Stoddard GJ, Jackson M, Esplin S & Rose NC 2017 Cell-free DNA, inflammation, and the initiation of spontaneous term labor. American Journal of Obstetrics and Gynecology 217 583. e1-583.e8. (https://doi.org/10.1016/j.ajog.2017.05.027)
24. Hui L & Bianchi DW 2011 Cell-free fetal nucleic acids in amniotic fluid. Human Reproduction Update 17 362-371. (https://doi.org/10.1093/humupd/dmq049)
25. Illanes S, Gomez R, Fornes R, Figueroa-Diesel H, Schepeler M, Searovic P, Serra R, Perez A & Nien JK 2011 Free fetal DNA levels in patients at risk of preterm labour. Prenatal Diagnosis 31 1082-1085. (https://doi.org/10.1002/pd.2838)
26. Jakobsen TR, Clausen FB, Rode L, Dziegiel MH & Tabor A 2012 High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery. Prenatal Diagnosis 32 840-845. (https://doi.org/10.1002/pd.3917)
27. Jung K, Fleischhacker M & Rabien A 2010 Cell-free DNA in the blood as a solid tumor biomarker - a critical appraisal of the literature. Clinica Chimica Acta 411 1611-1624. (https://doi.org/10.1016/j.cca.2010.07.032)
28. Kang X, Zhang X, Liu Z, Xu H, Wang T, He L & Zhao A 2015 Excessive TLR9 signaling contributes to the pathogenesis of spontaneous abortion through impairment of Treg cell survival by activation of Caspase 8/3. International Immunopharmacology 29 285-292. (https://doi.org/10.1016/j.intimp. 2015.11.004)
29. Krieg AM 2006 Therapeutic potential of toll-like receptor 9 activation. Nature Reviews Drug Discovery 5 471-484. (https://doi.org/10.1038/nrd2059)
30. Leung TN, Zhang J, Lau TK, Hjelm NM & Lo YM 1998 Maternal plasma fetal DNA as a marker for preterm labour. Lancet 352 1904-1905. (https://doi.org/10.1016/S0140-6736 (05) 60395-9)
31. Lim JH, Kim MH, Han YJ, Lee DE, Park SY, Han JY, Kim MY & Ryu HM 2013 Cell-free fetal DNA and cell-free total DNA levels in spontaneous abortion with fetal chromosomal aneuploidy. PLoS ONE 8 e56787. (https://doi.org/10.1371/journal.pone.0056787)
32. Lin Y, Liu X, Shan B, Wu J, Sharma S & Sun Y 2014 Prevention of CpG-induced pregnancy disruption by adoptive transfer of in vitro-induced regulatory T cells. PLoS ONE 9 e94702. (https://doi.org/10.1371/journal.pone.0094702)
33. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW & Wainscoat JS 1997 Presence of fetal DNA in maternal plasma and serum. Lancet 350 485-487. (https://doi.org/10.1016/S0140-6736 (97) 02174-0)
34. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM & Hjelm NM 1999 Rapid clearance of fetal DNA from maternal plasma. American Journal of Human Genetics 64 218-224. (https://doi.org/10.1086/302205)
35. Manokhina I, Singh TK, Peñaherrera MS & Robinson WP 2014 Quantification of cell-free DNA in normal and complicated pregnancies: overcoming biological and technical issues. PLoS ONE 9 e101500. (https://doi.org/10.1371/journal.pone.0101500)
36. Manokhina I, Wilson SL & Robinson WP 2015. Noninvasive nucleic acidbased approaches to monitor placental health and predict pregnancyrelated complications. American Journal of Obstetrics and Gynecology 213 S197-S206. (https://doi.org/10.1016/j.ajog.2015.07.010)
37. Marsman G, Zeerleder S & Luken BM 2016. Extracellular histones, cellfree DNA, or nucleosomes: differences in immunostimulation. Cell Death and Disease 7 e2518. (https://doi.org/10.1038/cddis.2016.410)
38. Masuzaki H, Miura K, Yoshiura K, Yoshimura S, Niikawa N & Ishimaru T 2004 Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism. Journal of Medical Genetics 41 289-292. (https://doi.org/10.1136/jmg.2003.015784)
39. McGlasson SL, Semple F, MacPherson H, Gray M, Davidson DJ & Dorin JR 2017 Human β-defensin 3 increases the TLR9-dependent response to bacterial DNA. European Journal of Immunology 47 658-664. (https://doi.org/10.1002/eji.201646799)
40. Nadeau-Vallée M, Obari D, Palacios J, Brien MÈ, Duval C, Chemtob S & Girard S 2016 Sterile inflammation and pregnancy complications: a review. Reproduction 152 R277-R292. (https://doi.org/10.1530/REP-16-0453)
41. Nakagawa Y & Gallo RL 2015 Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and macrophages. Journal of Immunology 194 1274-1284. (https://doi.org/10.4049/jimmunol.1402388)
42. Nishimoto S, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Murata C & Kim J-R 2016 Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance. Science Advances 2 e1501332. (https://doi.org/10.1126/sciadv. 1501332)
43. O'Neill LA, Golenbock D & Bowie AG 2013 The history of Toll-like receptors - redefining innate immunity. Nature Reviews Immunology 13 453-460.
44. Ori D, Murase M & Kawai T 2017 Cytosolic nucleic acid sensors and innate immune regulation. International Reviews of Immunology 36 74-88. (https://doi.org/10.1080/08830185.2017.1298749)
45. Orozco AF, Jorgez CJ, Horne C, Marquez-Do DA, Chapman MR, Rodgers JR, Bischoff FZ & Lewis DE 2008 Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsia. American Journal of Pathology 173 1595-1608. (https://doi.org/10.2353/ajpath.2008.080414)
46. Phillippe M 2014 Cell-free fetal DNA - a trigger for parturition. New England Journal of Medicine 370 2534-2536. (https://doi.org/10.1056/NEJMcibr1404324)
47. Phillippe M 2015 Cell-free fetal DNA, telomeres, and the spontaneous onset of parturition. Reproductive Sciences 22 1186-1201. (https://doi.org/10.1177/1933719115592714)
48. Poon LC, Musci T, Song K, Syngelaki A & Nicolaides KH 2013 Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes. Fetal Diagnosis and Therapy 33 215-223. (https://doi.org/10.1159/000346806)
49. Quezada MS, Francisco C, Dumitrascu-Biris D, Nicolaides KH & Poon LC 2015 Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm delivery. Ultrasound in Obstetrics and Gynecology 45 101-105. (https://doi.org/10.1002/uog.14666)
50. Reddy A, Zhong XY, Rusterholz C, Hahn S, Holzgreve W, Redman CW & Sargent IL 2008 The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia. Placenta 29 942-949. (https://doi.org/10.1016/j.placenta.2008.08.018)
51. Rinaldi SF, Makieva S, Frew L, Wade J, Thomson AJW, Moran CM, Norman JE & Stock SJ 2015 Ultrasound-guided intrauterine injection of lipopolysaccharide as a novel model of preterm birth in the mouse. American Journal of Pathology 185 1201-1206. (https://doi.org/10.1016/j.ajpath.2015.01.009)
52. Scharfe-Nugent A, Corr SC, Carpenter SB, Keogh L, Doyle B, Martin C, Fitzgerald KA, Daly S, O'Leary JJ & O'Neill LA 2012 TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia. Journal of Immunology 188 5706-5712. (https://doi.org/10.4049/jimmunol.1103454)
53. Sifakis S, Koukou Z & Spandidos DA 2015 Cell-free fetal DNA and pregnancy-related complications (review). Molecular Medicine Reports 11 2367-2372. (https://doi.org/10.3892/mmr.2014.3118)
54. Stein W, Müller S, Gutensohn K, Emons G & Legler T 2013 Cell-free fetal DNA and adverse outcome in low risk pregnancies. European Journal of Obstetrics and Gynecology and Reproductive Biology 166 10-13. (https://doi.org/10.1016/j.ejogrb.2012.09.006)
55. Stock SJ & Ismail KM 2016 Which intervention reduces the risk of preterm birth in women with risk factors? BMJ 355 i5206. (https://doi.org/10.1136/bmj.i5206)
56. Sun Y, Qin X, Shan B, Wang W, Zhu Q, Sharma S, Wu J & Lin Y 2013 Differential effects of the CpG-Toll-like receptor 9 axis on pregnancy outcome in nonobese diabetic mice and wild-type controls. Fertility and Sterility 99 1759-1767. (https://doi.org/10.1016/j.fertnstert.2013.01.121)
57. Taglauer ES, Wilkins-Haug L & Bianchi DW 2014 Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta 35 S64-S68. (https://doi.org/10.1016/j.placenta.2013.11.014)
58. Thaxton JE, Romero R & Sharma S 2009 TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. Journal of Immunology 183 1144-1154. (https://doi.org/10.4049/jimmunol.0900788)
59. Thurik FF, Lamain-de Ruiter M, Javadi A, Kwee A, Woortmeijer H, Page-Christiaens GC, Franx A, van der Schoot CE & Koster MP 2016 Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomes. Prenatal Diagnosis 36 1104-1111. (https://doi.org/10.1002/pd.4940)
60. Tong M & Chamley LW 2015 Placental extracellular vesicles and fetomaternal communication. Cold Spring Harbor Perspectives in Medicine 5 a023028. (https://doi.org/10.1101/cshperspect.a023028)
61. Tong M, Chen Q, Cree LM & Chamley LW 2017 Antiphospholipid antibodies increase the levels of mitochondrial DNA in placental extracellular vesicles: alarming for preeclampsia. Scientific Reports 7 16556. (https://doi.org/10.1038/s41598-017-16448-5)
62. Urato AC, Peter I, Canick J, Lambert-Messerlian G, Pulkkinen A, Knight G, Jeong YJ, Johnson KL & Bianchi DW 2008 Smoking in pregnancy is associated with increased total maternal serum cell-free DNA levels. Prenatal Diagnosis 28 186-190. (https://doi.org/10.1002/pd.1950)
63. van Boeckel SR, MacPherson H, Davidson DJ, Norman JE, Stock SJ 2017 Evaluating the Role of Cell-free Fetal DNA in Inflammation and Spontaneous Preterm Birth. bioRxiv. (https://doi.org/10.1101/191528)
64. Vollmer J 2006 TLR9 in health and disease. International Reviews of Immunology 25 155-181. (https://doi.org/10.1080/08830180600743107)
65. Wang E, Batey A, Struble C, Musci T, Song K & Oliphant A 2013 Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenatal Diagnosis 33 662-666. (https://doi.org/10.1002/pd.4119)
66. Yasuda K, Rutz M, Schlatter B, Metzger J, Luppa PB, Schmitz F, Haas T, Heit A, Bauer S & Wagner H 2006 CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA. European Journal of Immunology 36 431-436. (https://doi.org/10.1002/eji.200535210)